California State Teachers Retirement System trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 553,030 shares of the medical equipment provider's stock after selling 14,173 shares during the period. California State Teachers Retirement System owned about 0.16% of Intuitive Surgical worth $288,660,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. Geode Capital Management LLC increased its stake in Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the last quarter. Fisher Asset Management LLC increased its stake in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the last quarter. Norges Bank purchased a new position in Intuitive Surgical in the fourth quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. increased its stake in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after purchasing an additional 295,025 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Stock Up 1.3 %
NASDAQ ISRG opened at $514.59 on Monday. The firm has a 50-day moving average price of $511.92 and a 200 day moving average price of $533.05. Intuitive Surgical, Inc. has a 52-week low of $367.39 and a 52-week high of $616.00. The stock has a market capitalization of $183.29 billion, a P/E ratio of 80.28, a P/E/G ratio of 5.85 and a beta of 1.55.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the business posted $1.50 earnings per share. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
ISRG has been the topic of several recent analyst reports. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Citigroup increased their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Barclays decreased their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.
Get Our Latest Analysis on Intuitive Surgical
Insiders Place Their Bets
In other news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,454 shares of company stock worth $18,564,027. 0.70% of the stock is owned by company insiders.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report